Human umbilical cord bloodderived stromal cells suppress xenogeneic immune cell response in vitro

Croatian Medical Journal

Volumn 50, Issue 4, 2009, Pages 351-360

  Hao, Lei ^a   Zhang, Cheng ^a   Chen, Xing Hua ^a   Zou, Zhongmin ^a   Zhang, Xi ^a   Kong, Peiyan ^a   Liang, Xue ^a   Gao, Lei ^a   Peng, Xian Gui ^a   Sun, Aihua ^a   Wang, Qing Yu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOCORTIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROPIDIUM IODIDE; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; CRYOPRESERVATION; DENDRITIC CELL; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; SPLEEN CELL; STROMA CELL; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

ANTIGENS, CD; DENDRITIC CELLS; FETAL BLOOD; HUMANS; IMMUNOGENETIC PHENOMENA; IMMUNOSUPPRESSION; SPLEEN; STROMAL CELLS;

EID: 70649103096     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2009.50.351     Document Type: Article

References (68)

1. Friedenstein AJ, deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, et al. Precursors for fibroblasts in diferent populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2:83-92. Medline:4455512
2. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641-50. Medline:1870029 doi:10.1002/jor.1100090504
3. Owen M. Marrow stromal stem cells. J Cell Sci Suppl. 1988;10:63-76. Medline:3077943
4. Sale GE, Storb R. Bilateral diffuse pulmonary ectopic ossification after marrow allograft in a dog. evidence for allotransplantation of hemopoietic and mesenchymal stem cells. Exp Hematol. 1983;11:961-6. Medline:6420177
5. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. Clarification of the nomenclature for MSC: The International Society for Cellular therapy position statement. Cytotherapy. 2005;7:393-5. Medline:16236628 doi:10.1080/146532 40500319234
6. Kurosaka D, LeBien TW, Pribyl JA. Comparative studies of different stromal cell microenvironments in support of human B-cell development. Exp Hematol. 1999;27:1271-81. Medline:10428504 doi:10.1016/S0301-472X (99) 00067-3
7. Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, Chapuis B, et al. Recovery of immune reactivity after T-celldepleted bone marrow transplantation depends on thymic activity. Blood. 2000;96:2299-303. Medline:10979980
8. Dittel BN, LeBien TW. Reduced expression of vascular cell adhesion molecule-1 on bone marrow stromal cells isolated from marrow transplant recipients correlates with a reduced capacity to support human B lymphopoiesis in vitro. Blood. 1995;86:2833-41. Medline:7545475
9. Olsen NJ, Gu X, Kovacs WJ. Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J Clin Invest. 2001;108:1697-704. Medline:11733565
10. Li Y, Hisha H, Inaba M, Lian Z, Yu C, Kawamura M, et al. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: A role of stromal cells in positive selection. Exp Hematol. 2000;28:950-60. Medline:10989196 doi:10.1016/S0301-472X (00) 00483-5
11. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838-43. Medline:11986244 doi:10.1182/blood. V99.10.3838
12. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003;57:11-20. Medline:12542793 doi:10.1046/j.1365-3083.2003.01176.x (Pubitemid 38019084)
13. Potian JA, Aviv H, Ponzio NM, Harrison JS, Rameshwar P. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol. 2003;171:3426-34. Medline:14500637
14. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75:389-97. Medline:12589164 doi:10.1097/01. TP.0000045055.63901. A9
15. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, Mcintosh K, Patil S, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42-8. Medline:11823036 doi:10.1016/S0301-472X (01) 00769-X
16. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, et al. Immunosuppressive efect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102:3837-44. Medline:12881305 doi:10.1182/blood-2003-04-1193 (Pubitemid 37409409)
17. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101:3722-9. Medline:12506037 doi:10.1182/blood-2002-07-2104 (Pubitemid 36857965)
18. Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood. 2003;102:756-62. Medline:12663454 doi:10.1182/blood-2002-08-2628 (Pubitemid 36842003)
19. Korngold R, Sprent J. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J Immunol. 1985;135:3004-10. Medline:3876371
20. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells. 2006;24:2582-91. Medline:16873762 doi:10.1634/stemcells.2006-0228 (Pubitemid 44674320)
21. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, et al. Cotransplantation of HLA-identical sibling cultureexpanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005;11:389-98. Medline:15846293 doi:10.1016/j.bbmt. 2005.02.001 (Pubitemid 40542932)
22. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439-41. Medline:15121408 doi:10.1016/S0140-6736 (04) 16104-7
23. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue eng. 2001;7:211-28. Medline:11304456 doi:10.1089/ 107632701300062859 (Pubitemid 32295155)
24. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe We, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338-45. Medline:15579651 doi:10.1634/stemcells.2004-0058 (Pubitemid 39636409)
25. in 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003;102:1548-9. Medline:12900350 doi:10.1182/blood-2003-04-1291 (Pubitemid 36988070)
26. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22:625-34. Medline:15277708 doi:10.1634/stemcells.22-4-625
27. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004;200:123-35. Medline:15263023 doi:10.1084/jem.20040440 (Pubitemid 38982172)
28. Nishida S, Endo N, Yamagiwa H, Tanizawa T, Takahashi HE. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab. 1999;17:171-7. Medline:10757676 doi:10.1007/s007740050081 (Pubitemid 29403926)
29. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33:919-26. Medline:14678851 doi:10.1016/j.bone.2003.07.005 (Pubitemid 37543568)
30. Gao L, Chen X, Zhang X, Liu Y, Kong P, Peng X, et al. Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood Cd34+ cells in vitro. Blood Cells Mol Dis. 2006;36:322-8. Medline:16500123 doi:10.1016/j.bcmd.2005.12.036
31. Maccario R, Podestr M, Moretta A, Cometa A, Comoli P, Montagna D, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of Cd4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica. 2005;90:516-25. Medline:15820948
32. Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation. 2003;76:1208-13. Medline:14578755 doi:10.1097/01.tP.0000082540.43730.80 (Pubitemid 37339646)
33. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815-22. Medline:15494428 doi:10.1182/blood-2004-04-1559 (Pubitemid 40223708)
34. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223:77-92. Medline:10037236 doi:10.1016/S0022-1759 (98) 00204-X
35. Bieback K, Kluter H. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell res Ther. 2007;2:310-23. Medline:18220915 doi:10.2174/ 157488807782793763
36. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411:385-9. Medline:11357147 doi:10.1038/35077251 (Pubitemid 32467049)
37. Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, et al. Efect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow donor Program. N Engl J Med. 1998;339:1177-85. Medline:9780337 doi:10.1056/NEJM199810223391701 (Pubitemid 28482126)
38. Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med. 2006;57:403-17. Medline:16409157 doi:10.1146/annurev. med.57.051804.123642
39. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, Stro-1. Blood. 1991;78:55-62. Medline:2070060
40. Gronthos S, Graves SE, Ohta S, Simmons PJ. The Stro-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood. 1994;84:4164-73. Medline:7994030
41. Hutson EL, Boyer S, Genever PG. Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood. Tissue Eng. 2005;11:1407-20. Medline:16259596 doi:10.1089/ten. 2005.11.1407
42. Grinnemo KH, Mlnsson A, Dellgren G, Klingberg D, Wardell E, Drvota V, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg. 2004;127:1293-300. Medline:15115985 doi:10.1016/j.jtcvs.2003.07.037 (Pubitemid 38560590)
43. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000;6:1282-6. Medline:11062543 doi:10.1038/81395 (Pubitemid 30950859)
44. Webb S, Morris C, Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 1990;63:1249-56. Medline:2148123 doi:10.1016/0092-8674 (90) 90420-J
45. Waldmann H, Cobbold S. Regulating the immune response to transplants. a role for CD4+ regulatory cells? Immunity. 2001;14:399-406. Medline:11336685 doi:10.1016/S1074-7613 (01) 00120-0
46. Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M, et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutininactivated lymphocytes. Scand J Immunol. 2004;60:307-15. Medline:15320889 doi:10.1111/j.0300-9475.2004.01483.x (Pubitemid 39141263)
47. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res. 2006;312:2169-79. Medline:16631737 doi:10.1016/j.yexcr.2006.03.019 (Pubitemid 43928946)
48. Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC, Favrot MC. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia. 2005;19:1597-604. Medline:16049516 doi:10.1038/sj.leu.2403871 (Pubitemid 43090404)
49. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999;162:5317-26. Medline:10228007
50. Stephens LA, Mason D. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25-subpopulations. J Immunol. 2000;165:3105-10. Medline:10975823
51. Stephens LA, Mottet C, Mason D, Powrie F. Human CD4 (+) CD25 (+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol. 2001;31:1247-54. Medline:11298351 doi:10.1002/1521-4141 (200104) 31:4<1247:: Aid-iMMU1247>3.0. Co;2-M
52. Sakaguchi S. Animal models of autoimmunity and their relevance to human diseases. Curr Opin Immunol. 2000;12:684-90. Medline:11102773 doi:10.1016/S0952-7915 (00) 00163-1
53. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000;12:431-40. Medline:10795741 doi:10.1016/S1074-7613 (00) 80195-8
54. Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev. 2001;182:190-200. Medline:11722634 doi:10.1034/j.1600-065X.2001.1820115.x (Pubitemid 33070218)
55. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev. 2001;182:58-67. Medline:11722623 doi:10.1034/j.1600-065X.2001.1820104.x (Pubitemid 33070207)
56. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998;188:287-96. Medline:9670041 doi:10.1084/jem.188.2.287 (Pubitemid 28357757)
57. Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol. 2001;167:1137-40. Medline:11466326
58. Ermann J, Szanya V, Ford GS, Paragas V, Fathman CG, Lejon K. CD4 (+) CD25 (+) T cells facilitate the induction of T cell anergy. J Immunol. 2001;167:4271-5. Medline:11591749
59. Annacker O, Burlen-defranoux O, Pimenta-Araujo R, Cumano A, Bandeira A. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment. J Immunol. 2000;164:3573-80. Medline:10725712
60. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol. 2005;6:338-44. Medline:15785759 doi:10.1038/ni1180 (Pubitemid 41716770)
61. Picca CC, Caton AJ. The role of self-peptides in the development of CD4+ CD25+ regulatory T cells. Curr Opin Immunol. 2005;17:131-6. Medline:15766671 doi:10.1016/j.coi.2005.01.003 (Pubitemid 40343098)
62. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345-52. Medline:15785760 doi:10.1038/ni1178 (Pubitemid 41716771)
63. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811. Medline:10837075 doi:10.1146/annurev. immunol.18.1.767
64. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-52. Medline:9521319 doi:10.1038/32588 (Pubitemid 28155090)
65. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002;23:445-9. Medline:12200066 doi:10.1016/S1471-4906 (02) 02281-0
66. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005;105:4120-6. Medline:15692068 doi:10.1182/blood-2004-02-0586 (Pubitemid 40656164)
67. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol. 2006;177:2080-7. Medline:16887966
68. Zhang W, Ge W, Li C, You S, Liao L, Han Q, et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 2004;13:263-71. Medline:15186722 doi:10.1089/15473280432 3099190